Company Filing History:
Years Active: 2008
Title: Ann Poblenz: Innovator in Osteolytic Lesion Treatment
Introduction
Ann Poblenz is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of medical research, particularly in the treatment of bone-resorbing diseases. Her innovative work has the potential to impact many patients suffering from various conditions related to bone health.
Latest Patents
Ann Poblenz holds a patent for the invention titled "Inhibition of osteolytic lesions by SRC kinase inhibitors." This patent includes methods and compositions for treating bone-resorbing diseases or bone resorption related to pathologic conditions. These conditions include osteoporosis, arthritis, cancer metastases to the bone, and other related diseases. The invention addresses a range of cancers, such as breast cancer, prostate cancer, and multiple myeloma, as well as various arthritic conditions, particularly rheumatoid arthritis.
Career Highlights
Ann Poblenz is affiliated with the University of Texas System, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical treatments that can improve patient outcomes in bone health.
Collaborations
Some of her notable coworkers include Bryant G Darnay and Janet E Price. Their collaborative efforts contribute to the innovative research being conducted in the field of osteolytic lesions and related diseases.
Conclusion
Ann Poblenz is a pioneering inventor whose work in the treatment of osteolytic lesions showcases her dedication to improving medical science. Her contributions are vital for advancing therapies that address serious health conditions affecting bone integrity.